Vir Biotechnology, Inc. (VIR)

NASDAQ: VIR · Real-Time Price · USD

8.69

-0.65 (-6.96%)

At close: Jul 24, 2026, 4:00 PM EDT

8.69

0.00 (0.00%)

After-hours: Jul 24, 2026, 4:10 PM EDT

Vir Biotechnology Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65.5	68.56	74.21	86.18	1,616	1,095
Revenue Growth	213.96%	-7.61%	-13.89%	-94.67%	47.50%	1334.39%
Gross Profit	65.5	68.53	73.36	83.42	1,469	1,030
Operating Income	-472.05	-479.33	-587.17	-684.31	833.07	420.75
Net Income	-442.72	-437.99	-521.96	-615.06	515.84	528.58
Earnings Per Share	-3.13	-3.16	-3.83	-4.59	3.83	3.96
EPS Growth	-	-	-	-	-3.28%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	0.81	2.04	11.53	47.14	39.7	1,095
Foreign	64.69	66.52	62.68	39.04	1,576	-
Total	65.5	68.56	74.21	86.18	1,616	1,095

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	476.3	467.02	905.35	1,522	2,402	708.15
Total Debt	86.64	89.05	90.14	111.67	123.84	133.56
Net Cash (Debt)	389.66	377.96	815.21	1,411	2,278	574.58
Net Cash Growth	-45.39%	-53.64%	-42.21%	-38.08%	296.50%	-14.28%
Net Cash Per Share	2.76	2.73	5.98	10.52	16.90	4.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-446.05	-391.78	-446.35	-778.79	1,663	-47.59
Capital Expenditures	-2.93	-4.83	-7.3	-21.57	-68.01	-21.82
Free Cash Flow	-448.98	-396.61	-453.65	-800.36	1,595	-69.41
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	99.96%	98.86%	96.79%	90.94%	93.99%
Operating Margin	-720.73%	-699.18%	-791.27%	-794.04%	51.56%	38.41%
Pretax Margin	-675.35%	-638.56%	-704.95%	-728.93%	46.68%	50.19%
Profit Margin	-675.96%	-638.88%	-703.40%	-713.76%	31.92%	48.25%
FCF Margin	-685.52%	-578.52%	-611.35%	-928.71%	98.73%	-6.34%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	6.61	10.57
Forward PE	-	92.73	92.73	92.73	92.73	18.86
P/FCF Ratio	-	-	-	-	2.11	-
PS Ratio	22.56	12.27	13.55	15.73	2.09	5.01